Drug Search Results
More Filters [+]


Alternative Names: alosetron, gr68755, lotronex
Latest Update: 2023-09-02
Latest Update Note: News Article

Product Description

Alosetron is used to treat irritable bowel syndrome (IBS) in women who have diarrhea as their main symptom. This medicine is only used in severe cases of IBS that have not responded to other therapy. (Sourced from: https://www.mayoclinic.org/drugs-supplements/alosetron-oral-route/precautions/drg-20068243?p=1)

Mechanisms of Action: 5-HT3 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Chile | Peru | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Alosetron

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events